Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Vir Biotechnology
Company

Vir Biotechnology

Tracked across 2 events · 17 articles · First seen Feb 24, 2026 · Last active Feb 28, 2026

Sentiment
48
Attention
6
Events
2
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
2 10
Business
Vir Biotechnology Prices $150M Public Offering
Vir Biotechnology announced the pricing of its underwritten public offering of 17,647,058 shares of its common stock at $8.50 per share, expecting gross proceeds of $150 million. This offering will provide capital for its operations and development of medicines.
Feb 24, 2026 · 10 articles
6 85
Tech
VIR-5500 Shows Remarkable Prostate Cancer Results
Vir Biotechnology funded the phase one clinical trial of VIR-5500, which has yielded promising results. This success could significantly boost the company's reputation and future market position in oncology.
Feb 28, 2026 · 7 articles
Relationships (2)
Johann de Bono ↔ Vir Biotechnology Unknown
Institute of Cancer Research ↔ Vir Biotechnology Unknown
NEWSDESK
Track Vir Biotechnology live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.